-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
INTEGRATED BIOPHARMA INC quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2011 to Q3 2025.
- INTEGRATED BIOPHARMA INC Deferred Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $68K, a 65.5% decline year-over-year.
- INTEGRATED BIOPHARMA INC annual Deferred Income Tax Expense (Benefit) for 2025 was $1.26M, a 911% increase from 2024.
- INTEGRATED BIOPHARMA INC annual Deferred Income Tax Expense (Benefit) for 2024 was $125K, a 73.6% increase from 2023.
- INTEGRATED BIOPHARMA INC annual Deferred Income Tax Expense (Benefit) for 2023 was $72K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)